PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study

202185 citationsJournal Articlehybrid Open Access

Authors

Federica Branchi · Franklin University

Rolf D. Klingenberg-Noftz · Gemeinschaftskrankenhaus Havelhöhe

Kristina Friedrich · Franklin University

Nataly Bürgel · Franklin University

S Daum · Franklin University

Juliane Buchkremer · Franklin University

Elena Sonnenberg ·

Abstract

PuraStat expanded the therapeutic toolbox available for an effective treatment of gastrointestinal bleeding sources. It could be safely applied and administered without complications as a primary or secondary therapy. PuraStat may additionally serve as a bridge to surgery in order to achieve temporary haemostasis in case of refractory severe bleeding, possibly playing a role in preventing immediate emergency surgery.

Topics & Keywords

Gastrointestinal Bleeding Diagnosis and Treatment Gastrointestinal Tumor Research and Treatment Hemostasis and retained surgical items

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Surgical Endoscopy

Volume 36, Issue 5, pp. 2954-2961

DOI: 10.1007/s00464-021-08589-6

Field-Weighted Citation Impact: 8.07